Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/480999


Stem Cell - Analysis and Market Forecasts, 2006-2016


Description: Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to author Robin R. Young, a medical industry analyst who has been named one of The Wall Street Journal’s “Best on the Street” and among the top-10 analysts in the United States by Institutional Investor. By 2016, companies supplying stem cell products should generate more than $1.2 billion in total revenues and have a combined market value of over $10 billion. Find out about the latest stem cell applications and market trends through the Stem Cell Analysis and Market Forecasts 2006-2016. Almost 350 pages of industry-specific research with forecasts and profiles of more than 100 stem cell companies.


Contents: Introduction and Overview
Stem Cell Therapies as Disruptive Technologies
Stem Cells as In Vivo Drug Stores
Stem Cell Plasticity
Stem Cell Safety

The History of Stem Cells as a Therapy
Trauma and Fracture
Trauma and Fracture Care
Types of Fractures
The Gustillo-Anderson Classification of Open Injuries
Causes of Fractures
High-Energy Injuries
Low-Energy Injuries
Stress Fractures
The Biology of Fracture Healing
Stem Cell and Other Biologic Treatment of Fractures
Incidence of Fractures in the United States
Conventional Treatment of Fractures
Bone Graft Materials in Fresh Fracture Repair
Fresh Fracture Market Size
Average Selling Prices
Risks Associated With Fracture Repair

Cranial Maxillofacial
Maxillofacial Trauma
Causes of Maxillofacial Trauma
Common Fractures of Facial Bones
Nasoethmoid Orbital Fractures
Zygomatic Fractures
Mandibular Fractures
Symptoms
Internal Orbital Fractures
Maxillary Fractures
Symptoms
Soft Tissue Deformities
Stem Cell Approach for Treatment of Cranial Maxillofacial Fractures
Conventional Treatment for Common Types of Facial Fractures
Nasoethmoid Orbital Fractures
Zygomatic Fractures
Mandibular Fractures
Internal Orbital Fractures
Maxillary Fractures
Soft Tissue Deformities
Craniofacial Surgery
Cranial Vault (Skull) Surgery
Facial Bone Surgery
Orbital Surgery
Average Selling Prices for CMF Biomaterials
Stem Cell CMF Market Size

Cartilage Repair
The Biology of Cartilage
Hyaline Cartilage
Elastic Cartilage
Fibrous Cartilage
Causes of Cartilage Injury
Cellular Approaches to Cartilage Repair
Mesenchymal Stem Cells (MSCs) for Cartilage and Soft Tissue Repair
Scaffolds
Conventional Treatment for Cartilage Repair
Arthroscopic Chondroplasty (debridement)
Microfracture
Implant and Transplant Therapies
Autologous Chondrocyte Implant (ACI)
Eligibility
Complications of ACI Procedure
Results
Next-Generation ACI Procedures
Soft Tissue Grafts
Mosaicplasty and Osteochondral Autograft Transfer Systems (OATS)
Ostechondral Allograft Transfer Systems
Large Joint Reconstruction
Reasons for Knee or Hip Replacement
The Impact of Cellular Therapies on Large Joint Reconstruction
Knee Replacement Surgery
Types of Knee Implant Fixation
Risks of the Surgery
Hip Replacement Surgery
Cemented procedure
Non-cemented procedure
Risks of the Surgery

Large Joint Revision
Large Joint Revision Surgery
Knee Revision Surgery
Reasons for Knee Revision Surgery
Procedure
Risks
Alternative Surgical Procedures
Hip Revision Surgery
Reasons for Hip Revision Surgery
Procedure
Risks

Cardiovascular Disease
Basics of Cardiovascular Disease
Cardiovascular Disease—the Most Common Cause of Death Globally
Risk Factors for Cardiovascular Disease
Types of Cardiovascular Disease
Coronary Heart Disease
Stroke
Types of Stroke
Cardiomyopathy
Valvular Heart Disease
Pericardial Disease
Congenital Heart Disease
Congestive Heart Failure
Rheumatic Heart Disease
Stem Cell Treatment of Cardiovascular Disease
Animal Studies
Successful Clinical Results
Traditional Treatment of Coronary Heart Disease
Coronary Angioplasty or Balloon Angioplasty
Coronary Artery Bypass Graft (CABG)
Atherectomy
Laser Angioplasty
Treatment of Stroke
Carotid Endarterectomy
Cerebral Angioplasty
Tissue Plasminogen Activator (tPA)

Nerve Regeneration
The Human Nervous System
Peripheral Nervous System
Types of Nerve Injuries
Neuropraxia
Axonotmesis
Neurotmesis
Traumatic Injury
Non-Traumatic Injury
Nerve Regeneration and Recovery
Stem Cell Approach for Nerve Regeneration
Surgical Procedures for Nerve Injuries
Neurorrhaphy/Nerve Repair
Nerve Graft
Carpal Tunnel Syndrome
Open Release Surgery
Endoscopic Surgery

Anti-Inflammation
Mechanism of Action of Stem Cells in Mediating Inflammation in Humans
Graft vs Host Disease
Crohn’s Disease
Stem Cells for Inflammatory Disease
Beyond GVHD and Crohn’s Disease

Diabetes
The Basics of Diabetes
Diabetes—A Leading Cause of Death Worldwide
Stem Cell Approach
Challenges Faced by the Stem Cell Approach
Diabetes Management—The Conventional Approach

Company Profiles
DM Inc
Aastrom Biosciences, Inc
Advanced Cell Technology, Inc
Aegera Therapeutics Inc
Aldagen, Inc
AllCells LLC
Amersham Biosciences
Amgen
Angel Biotechnology
Applied Tissue Technologies LLC
Arteriocyte, Inc
Athersys, Inc
BeFutur Biotechnologies SA
Berlex, Inc
BioE, Inc
BioHeart, Inc
Cambrex Corporation
Cell Dynamics, LLC
Cell Genesys, Inc
Cellartis AB
Cellerant Therapeutics, Inc
Cellerix SL
CellGenix Technologie Transfer GmbH
CellResearch Corp Pte Ltd
CellTran Limited
Cellular Dynamics International Inc
Ceregene Inc
Chemokine Therapeutics Corp
Cognate BioServices, Inc
CorCell
Covance Inc
Cytomatrix LLC
Cytori Therapeutics, Inc
EmCell
ES Cell International PTE Ltd
Gamida Cell Ltd
Geron Corporation
Histostem Co Ltd
Incxyte Corporation
Intercytex Group plc
Ixion Biotechnology, Inc
Kaleidos Pharma, Inc
Living Cell Technologies Ltd
MD Biosciences Inc
Mesoblast Limited
MG Biotherapeutics, LLC
Moraga Biotechnology
NeoStem, Inc
NeuralStem Biopharmaceuticals, Ltd
NeuroNova AB
Neuronyx, Inc
Novartis AG
Novocell, Inc
NsGene A/S
Odontis Ltd
Oligene GmbH
Ortec International, Inc
PharmaStem Therapeutics, Inc
Pluristem Life Systems, Inc
Progenitor Cell Therapy, LLC
Proneuron Biotechnologies Inc
Quintiles Transnational Corp
RegeneRx Biopharmaceuticals, Inc
Regenetech, Inc
Regenics A/S
ReneMed Biologics, Inc
ReNeuron Group PLC
Reproductive Genetics Institute
Saneron CCEL Therapeutics, Inc
(Bayer) Schering Pharma AG
Serologicals Corporation (acquired by Millipore)
SinoCells BioTechnologies Co, Ltd
Stem Cell Sciences PLC
Stem Cell Therapeutics Corp
Stem Cells, Inc
StemCyte, Inc
StemCell Technologies Inc
StemPath Inc
Stemride International, Ltd
Tengion, Inc
TheraVitae Co, Ltd
Titan Pharmaceuticals, Inc
Transition Therapeutics Inc
TriStem Corporation
US Biodefense, Inc
Vesta Therapeutics, Inc
ViaCell, Inc
VistaGen Therapeutics Inc

APPENDIX


Companies Mentioned - DM Inc - Aastrom Biosciences, Inc - Advanced Cell Technology, Inc - Aegera Therapeutics Inc - Aldagen, Inc - AllCells LLC - Amersham Biosciences - Amgen - Angel Biotechnology - Applied Tissue Technologies LLC - Arteriocyte, Inc - Athersys, Inc - BeFutur Biotechnologies SA - Berlex, Inc - BioE, Inc - BioHeart, Inc - Cambrex Corporation - Cell Dynamics, LLC - Cell Genesys, Inc - Cellartis AB - Cellerant Therapeutics, Inc - Cellerix SL - CellGenix Technologie Transfer GmbH - CellResearch Corp Pte Ltd - CellTran Limited - Cellular Dynamics International Inc - Ceregene Inc - Chemokine Therapeutics Corp - Cognate BioServices, Inc - CorCell - Covance Inc - Cytomatrix LLC - Cytori Therapeutics, Inc - EmCell - ES Cell International PTE Ltd - Gamida Cell Ltd - Geron Corporation - Histostem Co Ltd - Incxyte Corporation - Intercytex Group plc - Ixion Biotechnology, Inc - Kaleidos Pharma, Inc - Living Cell Technologies Ltd - MD Biosciences Inc - Mesoblast Limited - MG Biotherapeutics, LLC - Moraga Biotechnology - NeoStem, Inc - NeuralStem Biopharmaceuticals, Ltd - NeuroNova AB - Neuronyx, Inc - Novartis AG - Novocell, Inc - NsGene A/S - Odontis Ltd - Oligene GmbH - Ortec International, Inc - PharmaStem Therapeutics, Inc - Pluristem Life Systems, Inc - Progenitor Cell Therapy, LLC - Proneuron Biotechnologies Inc - Quintiles Transnational Corp - RegeneRx Biopharmaceuticals, Inc - Regenetech, Inc - Regenics A/S - ReneMed Biologics, Inc - ReNeuron Group PLC - Reproductive Genetics Institute - Saneron CCEL Therapeutics, Inc - (Bayer) Schering Pharma AG - Serologicals Corporation (acquired by Millipore) - SinoCells BioTechnologies Co, Ltd - Stem Cell Sciences PLC - Stem Cell Therapeutics Corp - Stem Cells, Inc - StemCyte, Inc - StemCell Technologies Inc - StemPath Inc - Stemride International, Ltd - Tengion, Inc - TheraVitae Co, Ltd - Titan Pharmaceuticals, Inc - Transition Therapeutics Inc - TriStem Corporation - US Biodefense, Inc - Vesta Therapeutics, Inc - ViaCell, Inc - VistaGen Therapeutics Inc


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/480999

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 29/11/2009 22:35:42
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Stem Cell - Analysis and Market Forecasts, 2006-2016

Web Address:
http://www.researchandmarkets.com/reports/480999

Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €3,205.00 + EUR€ 50.00 Shipping/Handling *
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 29/11/2009 22:35:42


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)